Guest guest Posted April 22, 2007 Report Share Posted April 22, 2007 Dear forum, Yes this is a bold declaration from NACO chief !. But there is another situation evolving which may need immediate attention even before thinking second line. There are a large number of patients who cannot tolerate stavudine and zidovudine in the first line. We don’t have Tenofovir in the first line medicine and can not provide lamivudine and nevirapine from the program even if the patient can afford to bye Tenofovir ( Rs 1500 per month ). I feel our immediate need is to include tenofovir tablets for alternative first line and I am sure NACO will look into it. Altering the first line to Tenofovir/efavirenz/ emtricitabine is another option which may solve may other issues related to ARV. Dr Ajithkumar Trichur, Kerala e-mail: <ajisudha@...> Quote Link to comment Share on other sites More sharing options...
Guest guest Posted April 23, 2007 Report Share Posted April 23, 2007 Dear Forum, Re: /message/7176 Supporting the motion of Dr Ajithkumar, and adding: 1 Line alternative Tenofovir/efavirenz/ emtricitabine once a DAY tablet in FIX DRUG COMBINATION (FDC) like TRIOMUNE NOW IN THE INDIAN MARKET AT cost 5000 INR x month If we compare with 2 line TNF or ABC 3TC LPN/r or EFV 8 to 11 pills per day 10000 INR x month An efficient alternative before shift to 2 line!, and figures speaks for its one Thank you Dr. CARAVOTTA LIZANDRE Bld, Plot 38 GF,1A. St. BAPTIST Rd BANDRA West 400050 MUMBAI- INDIA e-mail: jorge.caravotta@... MOBILE: +91 9920041943 LAN line: +91 2226424819 http://drjorgecaravotta.com/ http://humanityfilms.blogspot.com/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.